Geneos Wealth Management’s Northrop Grumman NOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $549K | Buy |
1,078
+205
| +23% | +$118K | 0.01% | 707 |
|
|
2026
Q1 | $596K | Sell |
873
-72
| -8% | -$49.8K | 0.01% | 638 |
|
|
2025
Q4 | $539K | Buy |
945
+2
| +0.2% | +$1.16K | 0.01% | 640 |
|
|
2025
Q3 | $575K | Sell |
943
-1,511
| -62% | -$857K | 0.01% | 614 |
|
|
2025
Q2 | $1.23M | Buy |
2,454
+153
| +7% | +$75.2K | 0.03% | 483 |
|
|
2025
Q1 | $1.18M | Buy |
2,301
+252
| +12% | +$120K | 0.04% | 418 |
|
|
2024
Q4 | $962K | Buy |
2,049
+183
| +10% | +$92K | 0.03% | 431 |
|
|
2024
Q3 | $985K | Buy |
1,866
+1,279
| +218% | +$626K | 0.04% | 411 |
|
|
2024
Q2 | $256K | Buy |
587
+19
| +3% | +$8.68K | 0.01% | 644 |
|
|
2024
Q1 | $272K | Sell |
568
-6
| -1% | -$2.76K | 0.01% | 627 |
|
|
2023
Q4 | $269K | Sell |
574
-160
| -22% | -$75K | 0.01% | 600 |
|
|
2023
Q3 | $323K | Buy |
734
+63
| +9% | +$27.7K | 0.02% | 560 |
|
|
2023
Q2 | $306K | Buy |
671
+133
| +25% | +$60.3K | 0.02% | 587 |
|
|
2023
Q1 | $248K | Sell |
538
-347
| -39% | -$161K | 0.02% | 596 |
|
|
2022
Q4 | $483K | Buy |
885
+56
| +7% | +$29.2K | 0.03% | 433 |
|
|
2022
Q3 | $389K | Sell |
829
-526
| -39% | -$251K | 0.03% | 442 |
|
|
2022
Q2 | $658K | Sell |
1,355
-38
| -3% | -$17.5K | 0.03% | 423 |
|
|
2022
Q1 | $623K | Buy |
1,393
+84
| +6% | +$34.7K | 0.03% | 480 |
|
|
2021
Q4 | $506K | Buy |
1,309
+107
| +9% | +$39.9K | 0.02% | 573 |
|
|
2021
Q3 | $433K | Hold |
1,202
| – | – | 0.02% | 609 |
|
|
2021
Q2 | $443K | Sell |
1,202
-250
| -17% | -$90K | 0.02% | 586 |
|
|
2021
Q1 | $514K | Hold |
1,452
| – | – | 0.01% | 630 |
|
|
2020
Q4 | $384K | Sell |
1,452
-57
| -4% | -$17.4K | 0.02% | 615 |
|
|
2020
Q3 | $494K | Buy |
1,509
+13
| +0.9% | +$4.24K | 0.03% | 433 |
|
|
2020
Q2 | $451K | Sell |
1,496
-88
| -6% | -$28.9K | 0.03% | 434 |
|
|
2020
Q1 | $494K | Sell |
1,584
-114
| -7% | -$39.7K | 0.03% | 378 |
|
|
2019
Q4 | $588K | Buy |
1,698
+230
| +16% | +$80.9K | 0.03% | 408 |
|
|
2019
Q3 | $544K | Buy |
1,468
+132
| +10% | +$46.7K | 0.03% | 392 |
|
|
2019
Q2 | $431K | Sell |
1,336
-79
| -6% | -$23.6K | 0.03% | 445 |
|
|
2019
Q1 | $381K | Buy |
1,415
+132
| +10% | +$36K | 0.03% | 472 |
|
|
2018
Q4 | $310K | Buy |
1,283
+8
| +0.6% | +$2.21K | 0.02% | 478 |
|
|
2018
Q3 | $404K | Buy |
1,275
+94
| +8% | +$28.6K | 0.03% | 432 |
|
|
2018
Q2 | $363K | Hold |
1,181
| – | – | 0.03% | 390 |
|
|
2018
Q1 | $412K | Buy |
1,181
+1
| +0.1% | +$335 | 0.04% | 347 |
|
|
2017
Q4 | $362K | Sell |
1,180
-34
| -3% | -$10.2K | 0.03% | 390 |
|
|
2017
Q3 | $349K | Sell |
1,214
-39
| -3% | -$10.5K | 0.03% | 373 |
|
|
2017
Q2 | $321K | Buy |
1,253
+9
| +0.7% | +$2.25K | 0.03% | 382 |
|
|
2017
Q1 | $296K | Sell |
1,244
-142
| -10% | -$33.7K | 0.03% | 389 |
|
|
2016
Q4 | $322K | Sell |
1,386
-47
| -3% | -$10.9K | 0.04% | 350 |
|
|
2016
Q3 | $306K | Buy |
1,433
+110
| +8% | +$23.8K | 0.04% | 351 |
|
|
2016
Q2 | $293K | Buy |
1,323
+100
| +8% | +$21.1K | 0.04% | 355 |
|
|
2016
Q1 | $245K | Buy |
+1,223
| New | +$231K | 0.04% | 390 |
|
Other funds holding NOC
Geneos Wealth Management's NOC Position: Q2 2026 in Review
Geneos Wealth Management increased its Northrop Grumman (NOC) stake by 23% in Q2 2026, buying an estimated $118K and bringing the position to 1,078 shares worth $549K. The position accounts for 0.01% of the portfolio, ranked #707.
Geneos Wealth Management first reported a position in NOC in Q1 2016 and has held it in 42 quarters since. The position peaked at $1.23M in Q2 2025. 1,816 funds tracked by Wall St. Rank hold NOC as of Q2 2026.
- Geneos Wealth Management held 1,078 shares of Northrop Grumman worth $549K as of Q2 2026.
- Geneos Wealth Management bought 205 Northrop Grumman shares in Q2 2026, an estimated $118K.
- Northrop Grumman made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #707 holding.
- Geneos Wealth Management first reported a position in Northrop Grumman in Q1 2016 and has held it in 42 quarters since.
- Geneos Wealth Management's Northrop Grumman position peaked at $1.23M in Q2 2025.
- 1,816 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.